Grampian Bio-partners is a small venture capital fund founded by Andy Porter in partnership with founding scientists of Haptogen. They invests in early stage companies focused on immuno-technology and biologics platforms.
Scotland, United Kingdom
|2018-10-03||Vital Metrix||Series A||$2.99M|
|2017-10-04||Vital Metrix||Seed VC||$0.31M|
|2009-03-06||Antoxis||Unattributed||$0.42M||Kapital Venture Equity, Scottish Enterprise, and TRICAPITAL Angel Investors|